Company
ChinaHarbin Jixianglong Biotech Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Harbin Jixianglong Biotech Co., Ltd.. 1 FDA inspection on record (1 OAI), 1 Form 483, 1 warning letter, last inspected November 07, 2025.
Company Profile
This profile covers Harbin Jixianglong Biotech Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 1
- VAI
- 0
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 1
Inspected November 7, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 7, 2025 | OAI | Human Drugs · Drug Quality Assurance | 1293332 |
FDA documents
Form 483s (1)
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Sichuan Deebio Pharmaceutical Co., Ltd.
Qingdao Kangyuan Pharmaceutical Co. Ltd.
Jiangsu NHWA Pharmaceutical Co., Ltd.
Zhejiang Huazhou Pharmaceutical Co., Ltd.
Jiangsu Grand Xinyi Pharmaceutical Co., Ltd
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Jiangsu Alpha Pharmaceutical Co., Ltd.
Chongqing Daxin Pharmaceutical Co., Ltd.
Jilin Asymchem Pharmaceuticals Co., Ltd.
Hubei Gedian Humanwell Pharmaceutical Co., Ltd (Huanggang Site)
Company Information
Name
Harbin Jixianglong Biotech Co., Ltd.
FEI Number
3024038751
Address
China
Country
China
ID: b80f231a-2af4-453b-ad8d-0f27575c586a